Virginia Commonwealth University / Massachusetts General Hospital / National Institute of Allergy / Mass General Hospital / National Cancer Institute / University of Pennsylvania / FDA White Oak Campus / White Oak Conference Center / /
MedicalCondition
Psoriasis / MS / Disease / diseases / /
Organization
Harvard Medical School / National Cancer Institute / National Institute of Health / office of Executive Programs / office of New Drugs / FOOD AND DRUG ADMINISTRATION / Center for Cancer / University of Pennsylvania / Department of Dermatology / Virginia Commonwealth University / Perelman School of Medicine / Massachusetts General Hospital / National Institute of Allergy / Mass General Hospital / CENTER FOR DRUG EVALUATION AND RESEARCH / ADVISORY COMMITTEE / office of Clinical Pharmacology / /
Person
Introductory Remarks Tatiana Oussova / Moon Hee Choi / Elizabeth Smith / Lynn A. Drake / Safety Mark Levick / Kendall A. Marcus / Unmet Need Mark Lebwohl / Tatiana Oussova / Efficacy Charis Papavassilis / Julie Beitz / Erica Brittain / Rose Marie Caballero / Gavin Corcoran / David J. Margolis / George Vratsanos / Perspective Bruce Strober / / /
Position
Mathematical Statistician / medical officer at Actavis / Director 12 Office / Professor of Dermatology / Professor of Epidemiology / Consultant / Lead Clinical Pharmacologist 3 Division / OFFICER / Acting Deputy Director / head of R&D / Professor / Lecturer / diseases physician / Representative / industry representative / Acting Director / Division of Dermatology and 21 Dental Products / /
ProvinceOrState
Texas / New Jersey / Virginia / Maryland / Pennsylvania / Massachusetts / /
Microsoft Word[removed]FDA DODAC Meeting - Revised[removed]_Transcript_.doc